What Аскорил Treats: Main Uses and Benefits

The primary therapeutic benefit of this formulation is providing supportive symptomatic relief in respiratory conditions where both airway constriction and difficulty clearing mucus coexist. This combination is indicated for the symptomatic relief of productive cough associated with various bronchopulmonary disorders. This dual action supports patients by addressing cluster symptoms that create noticeable interference with daily stability.

The medicine is commonly used to help manage symptoms related to Bronchial Asthma, Chronic Obstructive Pulmonary Disease (COPD), Acute and Chronic Bronchitis, and symptomatic phases of conditions like pneumonia or bronchiectasis. It is applied when patients experience the combination of airway narrowing (causing wheezing and chest tightness) and the retention of thick, sticky phlegm. This product helps address groups of symptoms that may appear suddenly, offering supportive therapeutic benefit that helps ease the overall burden of distressing manifestations and assists with maintaining functional stability.

---

Quick Fact: Relief for Dual Symptoms

This formulation is typically used when patients experience the combination of airway constriction and retained mucus, supporting relief across both symptomatic areas.

Regulatory References

1. NAFDAC Greenbook Admin on Salbutamol, Bromhexine, and Guaifenesin

Official Eligibility and Contraindications

The eligibility profile for the Ascoril combination (Salbutamol, Bromhexine, Guaifenesin) is strictly defined by regulatory authorities to ensure patient safety. The medicine is intended for use in adults and children aged 2 years and older who do not have any prohibiting conditions.

Contraindicated Populations (Must Not Use)	Comorbidity Restrictions
Children under 2 years of age	Severe liver or kidney failure
Women who are pregnant or breastfeeding	Decompensated diabetes mellitus
Patients with known hypersensitivity to components	Tachyarrhythmia, Myocarditis, or certain Heart Defects
	Active gastric or duodenal ulcers

Conditional Use (Caution Required)

Official labeling specifies that the medicine should be used with caution in patients with conditions such as general hypertension, controlled diabetes mellitus, hyperthyroidism, and non-active gastric ulcers. These patients require careful clinical evaluation before the product can be used.

In summary, non-eligibility is determined by age, reproductive status, and the presence of severe or unstable pre-existing medical conditions, which are deemed absolute contraindications in regulatory documentation.

The use of Аскорил may involve interactions with specific medicine classes and products, primarily due to the combined action of its active components, which often include a bronchodilator (such as levosalbutamol or terbutaline) and a sedative component (often due to the presence of a cough suppressant or antihistamine in certain formulations). Awareness of these interactions is important to maintain safety during treatment.

General Interaction Warnings

Interacting Product Category	Potential Effect & Clinical Note
Alcohol (Ethanol)	Should be avoided. Alcohol can enhance the sedative effect of the medicine, significantly worsening central nervous system depression, leading to increased drowsiness, dizziness, and impaired mental focus.
Non-selective Beta-Blockers (e.g., Propranolol)	Concurrent use is generally not recommended. These medicines may reduce the bronchodilating effect of the drug's beta-agonist component and carry a risk of severe bronchospasm in susceptible patients.
Cough Suppressants / Antitussives (e.g., Codeine)	Avoid co-administration. The expectorant and mucolytic actions of this product are intended to help expel mucus. Taking antitussives that suppress the cough reflex may lead to the accumulation of secretions in the airways, increasing the risk of complications.
Diuretics (Water Pills)	Caution is advised. Diuretics, particularly high-dose loop diuretics, may increase the risk of developing hypokalemia (low potassium levels) when combined with the beta-agonist component (e.g., levosalbutamol or terbutaline).
MAO Inhibitors / Tricyclic Antidepressants	Use with extreme caution or avoid. These medicines can potentiate the cardiovascular side effects (e.g., increased heart rate or blood pressure) of the bronchodilator component.

Patients should inform their healthcare provider of all prescription drugs, over-the-counter medicines, and herbal supplements currently being taken to properly manage the risk of potential interactions, especially those affecting the heart, blood pressure, or alertness.

How Аскорил Works

Аскорил's action arises from the synergistic modulation of bronchial smooth muscle tone, mucolysis, and secretomotor activity by its three active components.

Salbutamol, a beta2-adrenergic receptor agonist, binds to beta2-receptors on bronchial smooth muscle cells. This activates adenylyl cyclase, increasing the intracellular concentration of cyclic adenosine monophosphate (cAMP). The elevated cAMP level modulates protein kinases, ultimately leading to the relaxation of the smooth muscle fibers.

Bromhexine acts as a mucolytic agent by chemically cleaving and depolymerizing acidic mucopolysaccharide fibers within the bronchial secretions. This results in a substantial decrease in the viscosity of the sputum.

Guaifenesin stimulates afferent vagal nerve endings in the gastric mucosa. This induces a reflex increase in the secretion of low-viscosity fluid from the respiratory glands, increasing the volume and further decreasing the viscosity of the total secretion, thereby promoting mucociliary clearance.

The administration of Аскорил is followed according to a protocol for oral use, available in both tablet and syrup forms. The standardized dosing regimen requires the medicine to be taken three times a day (TID).

Official Dosing and Frequency

For adults and children over 12 years, the usual prescribed dose is 10 mL of the oral solution or one tablet per administration. Dosing schedules for younger patients require age-specific adjustment. Children between 6 and 12 years are typically administered 5 mL to 10 mL of the syrup, while those between 2 and 6 years are generally given 5 mL, with supervision often advised for the youngest group.

Administration Timing and Limits

To ensure correct intake, the medicine is generally advised to be taken with or after food to help mitigate potential gastric discomfort. The syrup formulation carries the specific procedural instruction to shake the bottle well immediately before measuring the dose with an accurate device. Usage is defined as short-term, and the instructions mandate that continuous administration should not exceed 4 to 5 days; medical re-evaluation is necessary if the condition persists. If a scheduled dose is missed, the patient is instructed to skip the missed dose and resume the regular schedule, with the explicit restriction that the dose must not be doubled. This protocol defines the necessary steps for correct administration as detailed in prescribing information.

Аскорил: Recent Clinical Evidence

This section outlines how studies have evaluated patient outcomes in various respiratory conditions, specifically exploring properties relevant to inflammation and pain. The combination formulation typically includes a bronchodilator (salbutamol), an expectorant (guaifenesin), and a mucolytic agent (bromhexine).

---

Key Areas of Research Focus

1. Productive Cough and Bronchitis

Research has explored the use of the fixed-dose combination in treating productive cough associated with conditions like acute bronchitis and exacerbations of chronic bronchitis. A randomized controlled comparative trial involving patients with productive cough associated with various respiratory disorders assessed the three-component formulation against two-component alternatives.

• Trial Outcomes: Data from this comparative study reported improvement in a larger number of patients receiving the three-component combination compared to the two-component groups. The combination was also evaluated for effects on cough frequency, severity, and sputum characteristics over a short-term treatment period.

2. Safety and Tolerability

Non-interventional studies involving a large number of patients have investigated the effects of the formulation in various age groups (e.g., children over 3 years and adults). These large-scale observations primarily focused on the collection of safety data and the general tolerability profile in real-world clinical use. Trial scope included monitoring for adverse events such as increased heart rate, tremors, and gastrointestinal upset, which are typically associated with the bronchodilator component.

---

Conclusion of Evidence

Findings from clinical and observational research suggest that the combined approach may support the management of symptoms associated with tenacious bronchial secretions and bronchospasm. However, definitive, high-quality evidence regarding the superiority of this fixed-dose combination over single-agent therapies in routine management of acute respiratory infections remains a subject of ongoing discussion in respiratory guidelines.

Common questions about Аскорил (FAQ)

---

Q: Is Аскорил a type of antibiotic?

A: No, according to official product information, Аскорил is classified as an expectorant/bronchodilator combination medicine. It helps to open the airways and assist in mucus clearance, but it is not a type of antibiotic drug.

---

Q: How long does it typically take for Аскорил to start working?

A: The bronchodilator component in the medicine, Salbutamol, may have an effect in a relatively short timeframe. Pharmacokinetic data suggests that bronchodilation may begin within about 5 to 7 minutes after administration, with the maximum effect typically occurring around 50 minutes.

---

Q: Is Аскорил approved for treating asthma-related coughs?

A: Official regulatory indications state that this medicine is used for relieving coughs associated with various respiratory disorders. This includes conditions such as bronchial asthma, chronic bronchitis, and emphysema.

---

Q: What should be done if someone accidentally takes too much Аскорил?

A: In the event of potentially high intake, signs of overdosage are often an increase in the known side effects. These can include increased heart rate, dizziness, restlessness, and metabolic changes. Official guidance strongly advises seeking immediate medical attention if an overdosage is suspected.

---

Q: Is there a risk of becoming dependent on Аскорил?

A: The medicine is not classified as habit-forming. Official product information does not include warnings regarding dependence or addiction associated with its use.

---

Q: How long do the effects of a single dose of Аскорил typically last?

A: The duration of the effect is primarily determined by the bronchodilator component, Salbutamol. Official pharmacokinetic data indicates that the effects of a single dose typically last for 4 to 6 hours in most patients.

---

Q: Why does my doctor prescribe Аскорил if I have a wet cough?

A: Official guidance notes the medicine is intended for productive coughs, which may be described by users as a 'wet cough.' It contains multiple ingredients to relax the air passages and help thin and clear accumulated mucus from the lungs.

---

Q: Is it possible to use Аскорил for a dry cough?

A: Official product information indicates use in conditions with tenacious bronchial secretions and mucus production. Therefore, it is generally not characterized for use with a dry cough, which typically lacks sputum or mucus.

---

Q: Can Аскорил be taken with common cold and flu medications?

A: Regulatory warnings suggest avoiding co-administration with other cough suppressants or antitussives. This is because taking both may lead to the buildup of secretions in the airways, potentially increasing the risk of complications.

---

Q: Are there any specific foods or drinks to avoid while using Аскорил?

A: Official warnings describe that alcohol should be avoided during the use of this medicine. Alcohol can potentially enhance side effects such as increased dizziness or drowsiness.

---

Q: Can Аскорил cause sleepiness or drowsiness?

A: Official safety documents note that the medicine may cause dizziness or drowsiness in some individuals. Due to this potential effect, official safety advice suggests caution regarding activities requiring mental alertness, such as driving, until the individual's response to the medicine is known.

---

Q: Can Аскорил affect blood pressure?

A: The medicine should be used with caution in patients who have pre-existing conditions, including hypertension (high blood pressure). This is noted as an official precaution in the regulatory documentation.

---

Q: Why do some people experience restlessness after taking this medicine?

A: Feelings of restlessness may be related to the common side effects of the bronchodilator component, such as tremor or nervous tension. Restlessness itself is also listed as a potential symptom in the event of overdosage.

---

Q: What are the common reasons doctors recommend stopping Аскорил?

A: Regulatory warnings indicate that medical advice should be sought if the cough persists for more than one week. Discontinuation may also be recommended if a patient experiences severe side effects, such as paradoxical bronchospasm (unexpected worsening of breathing).

---

Q: Is Аскорил used for chronic lung conditions or just short-term coughs?

A: Official documentation indicates the medicine is used in conditions such as chronic bronchitis. However, its administration is defined for the short-term treatment of acute symptoms and exacerbations, typically lasting no more than 4 to 5 days.

---

Q: Why might a person switch from a single-ingredient cough medicine to Аскорил?

A: The medicine is a fixed-dose combination product designed to achieve a synergistic effect. This is based on the idea that the three active ingredients—bronchodilator, mucolytic, and expectorant—can simultaneously manage multiple facets of respiratory discomfort.

How to Store and Dispose of Ascoril?

The storage and disposal of Ascoril are strictly defined by official regulatory requirements to ensure the product's stability and safe handling.

Requirement Type	Official Labeled Condition
Temperature Restriction	Must be stored at a temperature not exceeding 30 C.
Protection Conditions	Must be protected from light and moisture.
Container Rules	Must be stored in the original container and kept tightly closed.
Child Safety	Must be kept out of the sight and reach of children.

Unused or expired Ascoril must be disposed of in accordance with local laws and regulations. Official instructions state that the medicine should not be discarded via wastewater or general household waste if specific local collection programs are available.